 | • レポートコード：B-GIR09D1966 • 出版社/出版日：GlobalInfoResearch / 2019年9月11日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール • 産業分類：医薬品・ヘルスケア |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、レジパスビルの世界市場について調べ、まとめました。種類別セグメントは、純度≥99％、純度<99％等、用途別セグメントは、C型肝炎、その他等に区分しました。レジパスビルの世界市場概観、メーカー動向、メーカー別レジパスビルシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・レジパスビルの市場概観 ・レジパスビルの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・レジパスビルの企業別販売動向、市場シェア、市場集中度、競争動向 ・レジパスビルの世界市場規模 ・レジパスビルの北米市場分析（アメリカ、カナダ、メキシコ等） ・レジパスビルのアメリカ市場規模推移 ・レジパスビルのカナダ市場規模推移 ・レジパスビルのメキシコ市場規模推移 ・レジパスビルのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・レジパスビルのドイツ市場規模推移 ・レジパスビルのイギリス市場規模推移 ・レジパスビルのロシア市場規模推移 ・レジパスビルのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・レジパスビルの日本市場規模推移 ・レジパスビルの中国市場規模推移 ・レジパスビルの韓国市場規模推移 ・レジパスビルのインド市場規模推移 ・レジパスビルの東南アジア市場規模推移 ・レジパスビルの南米市場分析（ブラジル、アルゼンチン等） ・レジパスビルの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・レジパスビルの種類別分析/販売量、売上、市場シェア（純度≥99％、純度<99％） ・レジパスビルの用途別分析/市場規模（C型肝炎、その他） ・レジパスビルの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・レジパスビルの販売チャネル・代理店・貿易業者・ディーラー分析 |
Ledipasvir is a direct acting antiviral (DAA) medication used as part of combination therapy to treat chronic Hepatitis C.
Scope of the Report:
The worldwide market for Ledipasvir is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Ledipasvir in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Tapi Teva
ForeFront Pharmaceutical
Neostar United Industrial
Gilead Sciences
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Purity ≥ 99%
Purity ＜ 99%
Market Segment by Applications, can be divided into
Hepatitis C
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ledipasvir product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Ledipasvir, with price, sales, revenue and global market share of Ledipasvir in 2017 and 2018.
Chapter 3, the Ledipasvir competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ledipasvir breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Ledipasvir market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Ledipasvir sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Ledipasvir Introduction
1.2 Market Analysis by Type
1.2.1 Purity ≥ 99%
1.2.2 Purity ＜ 99%
1.3 Market Analysis by Applications
1.3.1 Hepatitis C
1.3.2 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Tapi Teva
2.1.1 Business Overview
2.1.2 Ledipasvir Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Tapi Teva Ledipasvir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 ForeFront Pharmaceutical
2.2.1 Business Overview
2.2.2 Ledipasvir Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 ForeFront Pharmaceutical Ledipasvir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Neostar United Industrial
2.3.1 Business Overview
2.3.2 Ledipasvir Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Neostar United Industrial Ledipasvir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Gilead Sciences
2.4.1 Business Overview
2.4.2 Ledipasvir Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Gilead Sciences Ledipasvir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Ledipasvir Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Ledipasvir Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Ledipasvir Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Ledipasvir Manufacturer Market Share in 2018
3.3.2 Top 6 Ledipasvir Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Ledipasvir Market Analysis by Regions
4.1 Global Ledipasvir Sales, Revenue and Market Share by Regions
4.1.1 Global Ledipasvir Sales and Market Share by Regions (2014-2019)
4.1.2 Global Ledipasvir Revenue and Market Share by Regions (2014-2019)
4.2 North America Ledipasvir Sales and Growth Rate (2014-2019)
4.3 Europe Ledipasvir Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Ledipasvir Sales and Growth Rate (2014-2019)
4.5 South America Ledipasvir Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Ledipasvir Sales and Growth Rate (2014-2019)
5 North America Ledipasvir by Country
5.1 North America Ledipasvir Sales, Revenue and Market Share by Country
5.1.1 North America Ledipasvir Sales and Market Share by Country (2014-2019)
5.1.2 North America Ledipasvir Revenue and Market Share by Country (2014-2019)
5.2 United States Ledipasvir Sales and Growth Rate (2014-2019)
5.3 Canada Ledipasvir Sales and Growth Rate (2014-2019)
5.4 Mexico Ledipasvir Sales and Growth Rate (2014-2019)
6 Europe Ledipasvir by Country
6.1 Europe Ledipasvir Sales, Revenue and Market Share by Country
6.1.1 Europe Ledipasvir Sales and Market Share by Country (2014-2019)
6.1.2 Europe Ledipasvir Revenue and Market Share by Country (2014-2019)
6.2 Germany Ledipasvir Sales and Growth Rate (2014-2019)
6.3 UK Ledipasvir Sales and Growth Rate (2014-2019)
6.4 France Ledipasvir Sales and Growth Rate (2014-2019)
6.5 Russia Ledipasvir Sales and Growth Rate (2014-2019)
6.6 Italy Ledipasvir Sales and Growth Rate (2014-2019)
7 Asia-Pacific Ledipasvir by Country
7.1 Asia-Pacific Ledipasvir Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Ledipasvir Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Ledipasvir Revenue and Market Share by Country (2014-2019)
7.2 China Ledipasvir Sales and Growth Rate (2014-2019)
7.3 Japan Ledipasvir Sales and Growth Rate (2014-2019)
7.4 Korea Ledipasvir Sales and Growth Rate (2014-2019)
7.5 India Ledipasvir Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Ledipasvir Sales and Growth Rate (2014-2019)
8 South America Ledipasvir by Country
8.1 South America Ledipasvir Sales, Revenue and Market Share by Country
8.1.1 South America Ledipasvir Sales and Market Share by Country (2014-2019)
8.1.2 South America Ledipasvir Revenue and Market Share by Country (2014-2019)
8.2 Brazil Ledipasvir Sales and Growth Rate (2014-2019)
8.3 Argentina Ledipasvir Sales and Growth Rate (2014-2019)
8.4 Colombia Ledipasvir Sales and Growth Rate (2014-2019)
9 Middle East and Africa Ledipasvir by Countries
9.1 Middle East and Africa Ledipasvir Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Ledipasvir Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Ledipasvir Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Ledipasvir Sales and Growth Rate (2014-2019)
9.3 Turkey Ledipasvir Sales and Growth Rate (2014-2019)
9.4 Egypt Ledipasvir Sales and Growth Rate (2014-2019)
9.5 Nigeria Ledipasvir Sales and Growth Rate (2014-2019)
9.6 South Africa Ledipasvir Sales and Growth Rate (2014-2019)
10 Global Ledipasvir Market Segment by Type
10.1 Global Ledipasvir Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Ledipasvir Sales and Market Share by Type (2014-2019)
10.1.2 Global Ledipasvir Revenue and Market Share by Type (2014-2019)
10.2 Purity ≥ 99% Sales Growth and Price
10.2.1 Global Purity ≥ 99% Sales Growth (2014-2019)
10.2.2 Global Purity ≥ 99% Price (2014-2019)
10.3 Purity ＜ 99% Sales Growth and Price
10.3.1 Global Purity ＜ 99% Sales Growth (2014-2019)
10.3.2 Global Purity ＜ 99% Price (2014-2019)
11 Global Ledipasvir Market Segment by Application
11.1 Global Ledipasvir Sales Market Share by Application (2014-2019)
11.2 Hepatitis C Sales Growth (2014-2019)
11.3 Other Sales Growth (2014-2019)
12 Ledipasvir Market Forecast (2019-2024)
12.1 Global Ledipasvir Sales, Revenue and Growth Rate (2019-2024)
12.2 Ledipasvir Market Forecast by Regions (2019-2024)
12.2.1 North America Ledipasvir Market Forecast (2019-2024)
12.2.2 Europe Ledipasvir Market Forecast (2019-2024)
12.2.3 Asia-Pacific Ledipasvir Market Forecast (2019-2024)
12.2.4 South America Ledipasvir Market Forecast (2019-2024)
12.2.5 Middle East and Africa Ledipasvir Market Forecast (2019-2024)
12.3 Ledipasvir Market Forecast by Type (2019-2024)
12.3.1 Global Ledipasvir Sales Forecast by Type (2019-2024)
12.3.2 Global Ledipasvir Market Share Forecast by Type (2019-2024)
12.4 Ledipasvir Market Forecast by Application (2019-2024)
12.4.1 Global Ledipasvir Sales Forecast by Application (2019-2024)
12.4.2 Global Ledipasvir Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Ledipasvir Picture
Table Product Specifications of Ledipasvir
Figure Global Sales Market Share of Ledipasvir by Types in 2018
Table Ledipasvir Types for Major Manufacturers
Figure Purity ≥ 99% Picture
Figure Purity ＜ 99% Picture
Figure Ledipasvir Sales Market Share by Applications in 2018
Figure Hepatitis C Picture
Figure Other Picture
Figure United States Ledipasvir Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Ledipasvir Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Ledipasvir Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Ledipasvir Revenue (Value) and Growth Rate (2014-2024)
Figure France Ledipasvir Revenue (Value) and Growth Rate (2014-2024)
Figure UK Ledipasvir Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Ledipasvir Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Ledipasvir Revenue (Value) and Growth Rate (2014-2024)
Figure China Ledipasvir Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Ledipasvir Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Ledipasvir Revenue (Value) and Growth Rate (2014-2024)
Figure India Ledipasvir Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Ledipasvir Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Ledipasvir Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Ledipasvir Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Ledipasvir Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Ledipasvir Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Ledipasvir Revenue (Value) and Growth Rate (2014-2024)
Table Tapi Teva Basic Information, Manufacturing Base and Competitors
Table Tapi Teva Ledipasvir Type and Applications
Table Tapi Teva Ledipasvir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table ForeFront Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table ForeFront Pharmaceutical Ledipasvir Type and Applications
Table ForeFront Pharmaceutical Ledipasvir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Neostar United Industrial Basic Information, Manufacturing Base and Competitors
Table Neostar United Industrial Ledipasvir Type and Applications
Table Neostar United Industrial Ledipasvir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table Gilead Sciences Ledipasvir Type and Applications
Table Gilead Sciences Ledipasvir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Ledipasvir Sales by Manufacturer (2017-2018)
Figure Global Ledipasvir Sales Market Share by Manufacturer in 2017
Figure Global Ledipasvir Sales Market Share by Manufacturer in 2018
Table Global Ledipasvir Revenue by Manufacturer (2017-2018)
Figure Global Ledipasvir Revenue Market Share by Manufacturer in 2017
Figure Global Ledipasvir Revenue Market Share by Manufacturer in 2018
Figure Top 3 Ledipasvir Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Ledipasvir Manufacturer (Revenue) Market Share in 2018
Figure Global Ledipasvir Sales and Growth Rate (2014-2019)
Figure Global Ledipasvir Revenue and Growth Rate (2014-2019)
Table Global Ledipasvir Sales by Regions (2014-2019)
Table Global Ledipasvir Sales Market Share by Regions (2014-2019)
Table Global Ledipasvir Revenue by Regions (2014-2019)
Figure Global Ledipasvir Revenue Market Share by Regions in 2014
Figure Global Ledipasvir Revenue Market Share by Regions in 2018
Figure North America Ledipasvir Sales and Growth Rate (2014-2019)
Figure Europe Ledipasvir Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Ledipasvir Sales and Growth Rate (2014-2019)
Figure South America Ledipasvir Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Ledipasvir Sales and Growth Rate (2014-2019)
Figure North America Ledipasvir Revenue and Growth Rate (2014-2019)
Table North America Ledipasvir Sales by Countries (2014-2019)
Table North America Ledipasvir Sales Market Share by Countries (2014-2019)
Figure North America Ledipasvir Sales Market Share by Countries in 2014
Figure North America Ledipasvir Sales Market Share by Countries in 2018
Table North America Ledipasvir Revenue by Countries (2014-2019)
Table North America Ledipasvir Revenue Market Share by Countries (2014-2019)
Figure North America Ledipasvir Revenue Market Share by Countries in 2014
Figure North America Ledipasvir Revenue Market Share by Countries in 2018
Figure United States Ledipasvir Sales and Growth Rate (2014-2019)
Figure Canada Ledipasvir Sales and Growth Rate (2014-2019)
Figure Mexico Ledipasvir Sales and Growth Rate (2014-2019)
Figure Europe Ledipasvir Revenue and Growth Rate (2014-2019)
Table Europe Ledipasvir Sales by Countries (2014-2019)
Table Europe Ledipasvir Sales Market Share by Countries (2014-2019)
Table Europe Ledipasvir Revenue by Countries (2014-2019)
Figure Europe Ledipasvir Revenue Market Share by Countries in 2017
Figure Europe Ledipasvir Revenue Market Share by Countries in 2018
Figure Germany Ledipasvir Sales and Growth Rate (2014-2019)
Figure UK Ledipasvir Sales and Growth Rate (2014-2019)
Figure France Ledipasvir Sales and Growth Rate (2014-2019)
Figure Russia Ledipasvir Sales and Growth Rate (2014-2019)
Figure Italy Ledipasvir Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Ledipasvir Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Ledipasvir Sales by Countries (2014-2019)
Table Asia-Pacific Ledipasvir Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Ledipasvir Sales Market Share by Countries 2018
Table Asia-Pacific Ledipasvir Revenue by Countries (2014-2019)
Figure Asia-Pacific Ledipasvir Revenue Market Share by Countries 2018
Figure China Ledipasvir Sales and Growth Rate (2014-2019)
Figure Japan Ledipasvir Sales and Growth Rate (2014-2019)
Figure Korea Ledipasvir Sales and Growth Rate (2014-2019)
Figure India Ledipasvir Sales and Growth Rate (2014-2019)
Figure Southeast Asia Ledipasvir Sales and Growth Rate (2014-2019)
Figure South America Ledipasvir Revenue and Growth Rate (2014-2019)
Table South America Ledipasvir Sales by Countries (2014-2019)
Table South America Ledipasvir Sales Market Share by Countries (2014-2019)
Figure South America Ledipasvir Sales Market Share by Countries in 2018
Table South America Ledipasvir Revenue by Countries (2014-2019)
Table South America Ledipasvir Revenue Market Share by Countries (2014-2019)
Figure South America Ledipasvir Revenue Market Share by Countries in 2018
Figure Brazil Ledipasvir Sales and Growth Rate (2014-2019)
Figure Argentina Ledipasvir Sales and Growth Rate (2014-2019)
Figure Colombia Ledipasvir Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Ledipasvir Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Ledipasvir Sales by Countries (2014-2019)
Table Middle East and Africa Ledipasvir Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Ledipasvir Sales Market Share by Countries in 2018
Table Middle East and Africa Ledipasvir Revenue by Countries (2014-2019)
Table Middle East and Africa Ledipasvir Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Ledipasvir Revenue Market Share by Countries in 2014
Figure Middle East and Africa Ledipasvir Revenue Market Share by Countries in 2018
Figure Saudi Arabia Ledipasvir Sales and Growth Rate (2014-2019)
Figure UAE Ledipasvir Sales and Growth Rate (2014-2019)
Figure Egypt Ledipasvir Sales and Growth Rate (2014-2019)
Figure Nigeria Ledipasvir Sales and Growth Rate (2014-2019)
Figure South Africa Ledipasvir Sales and Growth Rate (2014-2019)
Table Global Ledipasvir Sales by Type (2014-2019)
Table Global Ledipasvir Sales Share by Type (2014-2019)
Table Global Ledipasvir Revenue by Type (2014-2019)
Table Global Ledipasvir Revenue Share by Type (2014-2019)
Figure Global Purity ≥ 99% Sales Growth (2014-2019)
Figure Global Purity ≥ 99% Price (2014-2019)
Figure Global Purity ＜ 99% Sales Growth (2014-2019)
Figure Global Purity ＜ 99% Price (2014-2019)
Table Global Ledipasvir Sales by Application (2014-2019)
Table Global Ledipasvir Sales Share by Application (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Ledipasvir Sales, Revenue and Growth Rate (2019-2024)
Table Global Ledipasvir Sales Forecast by Regions (2019-2024)
Table Global Ledipasvir Market Share Forecast by Regions (2019-2024)
Figure North America Sales Ledipasvir Market Forecast (2019-2024)
Figure Europe Sales Ledipasvir Market Forecast (2019-2024)
Figure Asia-Pacific Sales Ledipasvir Market Forecast (2019-2024)
Figure South America Sales Ledipasvir Market Forecast (2019-2024)
Figure Middle East and Africa Sales Ledipasvir Market Forecast (2019-2024)
Table Global Ledipasvir Sales Forecast by Type (2019-2024)
Table Global Ledipasvir Market Share Forecast by Type (2019-2024)
Table Global Ledipasvir Sales Forecast by Application (2019-2024)
Table Global Ledipasvir Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
世界の高純度テルル化スズ市場予測（～2024年） Scope of the Report: The worldwide market for High Purity Tin Telluride is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the High Purity T…- 世界の高純度ネオペンチルグリコール市場予測（～2024年） Neopentyl glycol (NPG, IUPAC name 2,2-dimethyl-1,3-propanediol) is an important industrial intermediate used in the synthesis of polyesters, especially resins for airplane or boat manufacturing. Scope of the Report: The worldwide market for High Purity Neopentyl Glycol is expected to grow at a CAGR …
- 世界の高純度リン化亜鉛市場予測（～2024年） Scope of the Report: The worldwide market for High Purity Zinc Phosphide is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the High Purity …
- 世界の高純度テルル化亜鉛市場予測（～2024年） Scope of the Report: The worldwide market for High Purity Zinc Telluride is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the High Purity …
- 世界の高純度ヒ化亜鉛（ZnAs2）市場予測（～2024年） Scope of the Report: The worldwide market for High Purity Zinc Arsenide (ZnAs2, CAS 12044-55-2) is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focu…